Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access

Christopher da Costa, Ben J Marais, Delia Goletti, Philip Onyebujoh, Jeremiah Chakaya, Gerhard Walzl, Alimuddin Zumla

Open source

DOI
10.1016/j.lanmic.2026.101443
Published
2026-07
Container
The Lancet Microbe
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2026.101443,
  title = {Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access},
  author = {Christopher da Costa and Ben J Marais and Delia Goletti and Philip Onyebujoh and Jeremiah Chakaya and Gerhard Walzl and Alimuddin Zumla},
  year = {2026},
  journal = {The Lancet Microbe},
  doi = {10.1016/j.lanmic.2026.101443},
  url = {https://doi.org/10.1016/j.lanmic.2026.101443}
}

RIS

TY  - JOUR
TI  - Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access
AU  - Christopher da Costa
AU  - Ben J Marais
AU  - Delia Goletti
AU  - Philip Onyebujoh
AU  - Jeremiah Chakaya
AU  - Gerhard Walzl
AU  - Alimuddin Zumla
PY  - 2026
JO  - The Lancet Microbe
DO  - 10.1016/j.lanmic.2026.101443
UR  - https://doi.org/10.1016/j.lanmic.2026.101443
ER  - 

APA

Costa, C. D., Marais, B. J., Goletti, D., Onyebujoh, P., Chakaya, J., Walzl, G., & Zumla, A. (2026). Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2026.101443

Source records